Apimeds Pharmaceuticals US APUS
NYSE APUS
$3.10 -0.15 (-4.77%)
As of: Oct 22, 2026 · 3:57 PM EDT

Apimeds Pharmaceuticals US (APUS) Net Equity Issued and Repurchased (2025)

Updated

Apimeds Pharmaceuticals US (APUS) reported Net Equity Issued and Repurchased of -$323,319 for Q4 2025.

Analysis

Apimeds Pharmaceuticals US (APUS) Net Equity Issued and Repurchased (2025) Analysis & Trends

For FY2025, Apimeds Pharmaceuticals US posted Net Equity Issued and Repurchased of $11.63 million.

  • By year, Net Equity Issued and Repurchased came in at $1.06 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -966.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -9.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 6.00 Mn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -346.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Apimeds Pharmaceuticals US 5.39 Mn -14.24 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -323,319.00
Sep 30, 2025 323,319.00
API Access

Apimeds Pharmaceuticals US Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=APUS&period=max&api_key=YOUR_API_KEY